Longevity & AgingiPSC Models Reveal SETBP1 as Master Chromatin Regulator in Blood Cancer Predisposition
Researchers used human induced pluripotent stem cells (iPSCs) with precise genome editing to model GATA2 deficiency, a leading cause of hereditary pediatric myelodysplastic neoplasms (MDS). By recreating stepwise mutational trajectories—GATA2 alone, then combined with SETBP1 and/or ASXL1 mutations—they found that GATA2 mutation alone has limited impact on hematopoietic progenitors. However, adding SETBP1 or ASXL1 mutations impairs myeloid differentiation, and combining all three severely depletes myeloid progenitors, faithfully recapitulating GATA2-related MDS. Strikingly, SETBP1 mutation dominates chromatin accessibility reprogramming even in the presence of ASXL1, establishing a stable epigenetic landscape that drives disease progression.
